Paradigm Biocapital Advisors LP - IMMATICS N.V ownership

IMMATICS N.V's ticker is IMTX and the CUSIP is N44445109. A total of 1 filers reported holding IMMATICS N.V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of IMMATICS N.V
ValueSharesWeighting
Q3 2023$23,836,816
+4.1%
2,058,447
+3.7%
1.62%
-8.6%
Q2 2023$22,904,7421,984,8131.77%
Other shareholders
IMMATICS N.V shareholders Q4 2023
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 697,431$4,8121.85%
Nantahala Capital Management 2,748,527$18,964,8361.45%
Sofinnova Investments, Inc. 3,132,694$21,615,5891.38%
SPHERA FUNDS MANAGEMENT LTD. 780,852$5,387,8790.90%
SILVERARC CAPITAL MANAGEMENT, LLC 282,432$1,948,7810.80%
Perceptive Advisors 3,491,500$24,091,3500.71%
Samsara BioCapital, LLC 495,000$3,415,5000.71%
683 Capital Management, LLC 1,334,937$9,211,0650.69%
Rock Springs Capital Management LP 2,513,923$17,346,0690.41%
Baker Brothers Advisors 5,187,081$35,790,8590.20%
View complete list of IMMATICS N.V shareholders